NCT05814055招募中2 期
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 76
- 试验地点
- 1
- 主要终点
- Subject Compliance with Intervention
研究概览
简要总结
This study will evaluate the compliance with a daily kava regimen among active smokers who have an intention to quit smoking. This study will also investigate whether kava use can facilitate tobacco cessation, reduce stress, and improve sleep.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 21 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adults aged 21 years or above (legal age for smoking in the U.S.) up to 75 years old;
- •self-reported smoking at least 5 cigarettes/day for the past year with INTENTION to quit at time of screening visit;
- •expired carbon monoxide level of more than 8 ppm at recruitment;
- •willingness to participate in the proposed study, as indicated by signed informed consent;
- •access to a functional telephone;
- •expected presence in the study's geographical area for the next 4 months;
- •not currently enrolled in any smoking cessation programs per self report; and
- •female subjects of childbearing potential will be required to practice acceptable methods of birth control (the acceptable methods of birth control include birth control pills, Birth Control Shot, Birth Control Implant, IUD, Diaphragm, and cervical cap).
- •if a participant takes kava dietary supplement, a 2-week washout period is needed for the participant to initiate this study or if a participant participated in a kava trial before, such as the kava JEK trial, the participant could be enrolled if the inclusion criteria above are met, including the 2-week washout period.
排除标准
- •history of active cancer (other than non-melanoma skin cancer) within the past 2 years;
- •diagnosed with liver dysfunction or with previous liver diseases;
- •levels of alanine transaminase, aspartate transaminase, alkaline phosphatase or total bilirubin over limit of normal (ULN) range at prescreen;
- •inability to refrain from acetaminophen, alcohol (no more than one drink daily via self-report), or other potentially hepatotoxic substances;
- •are pregnant or nursing (lactating) or of childbearing age planning to become pregnant or unwilling to use adequate contraception during the study;
- •participant answered "Yes" to any of the Modified Ask Suicide Screening Questions questions 1 through 3, or refuses to answer all of the questions. If subject answers 'Yes' to question 4 but the most recent suicide attempt took place >12 months from screening visit then subject is still eligible.
研究组 & 干预措施
AB-free kava
Experimental
干预措施: AB-free kava (Drug)
Placebo control
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Subject Compliance with Intervention
时间窗: 4 weeks
Evaluate subject compliance with the kava intervention, as measured by participant reported number of missed doses
次要结局
- Tobacco cessation(12 weeks)
- Effect on stress(12 weeks)
- Effect on sleep(12 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Effectiveness of a Smoking Cessation Intervention in a Mental Health Day HospitalTobacco Use DisorderSmoking CessationMental DisorderNCT05045326Hospital Clinic of Barcelona150
Enrolling By Invitation
不适用
Effectiveness of Smoking Cessation Program in a Community Health SystemSmoking CessationNCT05107687Virtua Health, Inc.76
进行中（未招募）
不适用
Smoking Cessation Intervention for Cancer PatientsNewly Diagnosed Cancer PatientsNCT00575718Memorial Sloan Kettering Cancer Center204
已完成
不适用
Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2016Smoking CessationNCT02804880The University of Hong Kong1,200
已完成
不适用
Yoga for Men Attempting Smoking CessationSmoking CessationNCT02055326The Miriam Hospital38